Carregant...

GENERIC DRUGS IN THE UNITED STATES: POLICIES TO ADDRESS PRICING AND COMPETITION

The cost of prescription drugs in the U.S. continues to be a source of concern for patients, caregivers, and policymakers. Drug prices typically decline rapidly once generic drugs receive U.S. Food and Drug Administration (FDA) approval and enter the market, but the past decade has witnessed rising...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Pharmacol Ther
Autors principals: Gupta, Ravi, Shah, Nilay D., Ross, Joseph S.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6355356/
https://ncbi.nlm.nih.gov/pubmed/30471089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1314
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!